# Gradient Centrifugation of Blood: Protocol and Principles

## Introduction to Gradient Centrifugation of Blood

Gradient centrifugation of blood is a preparative technique that separates blood components on the basis of their buoyant density by centrifuging whole blood or buffy coat over a medium of defined density. The method exploits the physical principle that particles sediment through a liquid medium at rates determined by their size, shape, and density relative to the surrounding medium. When blood is layered onto a density gradient medium and centrifuged, erythrocytes, granulocytes, and mononuclear cells (lymphocytes and monocytes) migrate to positions where their buoyant density equals that of the surrounding medium, forming distinct bands that can be harvested individually.

The technique is distinct from differential centrifugation, which separates particles solely by sedimentation rate through a homogeneous medium. In [density gradient centrifugation](/knowledge/molecular-biology/density-gradient-centrifugation), the gradient itself—whether pre-formed or generated during centrifugation—provides a density continuum that allows separation of particles with very similar sedimentation coefficients but different buoyant densities. This is the method of choice for isolating peripheral blood mononuclear cells (PBMCs), platelets, granulocytes, and, with appropriate modifications, rare cell populations such as [circulating tumor cells](/knowledge/molecular-biology/circulating-tumor-cells). The underlying physics is covered in detail in the [Principle and Working of Centrifugation](/knowledge/molecular-biology/principle-and-working-of-centrifugation), but the practical application to blood requires careful attention to medium selection, centrifugation parameters, and post-separation handling.

### Applications in Research and Clinical Labs

The most common application is the isolation of PBMCs for immunophenotyping, functional assays, activation studies, and downstream molecular analyses such as [RNA sequencing](/blog/guides/rna-sequencing) or chromatin immunoprecipitation. Clinical laboratories use gradient centrifugation for preparing cell populations for hematopoietic stem cell transplantation, for removing red blood cells from cord blood units, and for isolating plasma for coagulation studies. Research applications extend to the enrichment of [circulating tumor cells](/knowledge/molecular-biology/circulating-tumor-cells) from peripheral blood for [Tumor DNA in Blood](/knowledge/molecular-biology/tumor-dna-in-blood) analysis, the isolation of granulocytes for oxidative burst assays, and the preparation of platelet-rich plasma for studies of platelet function. The technique is also a prerequisite for many downstream protocols, including [Sanger Sequencing Protocol](/knowledge/molecular-biology/sanger-sequencing-protocol) when genomic DNA must be prepared from purified leukocyte populations rather than whole blood.

### Overview of Blood Components and Densities

Human blood is a complex mixture of cells suspended in plasma. The major cellular components and their approximate buoyant densities at 20–25 °C are:

| Component | Density (g/mL) | Diameter (µm) | Relative Abundance (per µL) |
|-----------|---------------|---------------|----------------------------|
| Plasma | 1.025–1.029 | — | — |
| Platelets | 1.04–1.06 | 2–3 | 150,000–400,000 |
| Monocytes | 1.067–1.077 | 12–20 | 200–800 |
| Lymphocytes | 1.065–1.077 | 7–15 | 1,000–4,800 |
| Granulocytes (neutrophils, eosinophils, basophils) | 1.080–1.095 | 10–15 | 3,000–7,000 |
| Erythrocytes | 1.090–1.110 | 7–8 | 4,500,000–5,500,000 |

These density differences are the basis for separation. The key observation is that lymphocytes and monocytes have densities below 1.077 g/mL, while erythrocytes and granulocytes are denser. A medium with a density of 1.077 g/mL will therefore retain mononuclear cells at the sample–medium interface while allowing erythrocytes and granulocytes to sediment through. This is the principle underlying Ficoll-Paque separation, the most widely used protocol for PBMC isolation.

## Principles of Density Gradient Separation

### Sedimentation Rate and Buoyant Density

The behavior of a particle in a centrifugal field is described by the sedimentation equation:

v = (d²(ρp − ρm)ω²r) / (18η)

where v is the sedimentation velocity, d is the particle diameter, ρp is the particle density, ρm is the medium density, ω is the angular velocity, r is the radial distance from the axis of rotation, and η is the medium viscosity. The term (ρp − ρm) is the buoyant density difference. If the particle is denser than the medium, it sediments; if less dense, it floats; if equal, it remains suspended at that position.

In a density gradient, the medium density increases with depth. A particle sediments until it reaches a region where ρm equals ρp, at which point the net force is zero and the particle bands at its isopycnic position. This is the principle of isopycnic (equilibrium) centrifugation. In practice, blood cell separation using Ficoll-Paque or Percoll is a hybrid approach: the cells sediment through the medium until they reach a density interface, where they accumulate because the medium below is denser than the cells. The separation is therefore rate-dependent (cells must sediment through the upper layer) and density-dependent (cells must be less dense than the lower layer). A more detailed treatment of these physical principles is available in the article on [Density Gradient Centrifugation](/knowledge/molecular-biology/density-gradient-centrifugation).

### Continuous vs. Discontinuous Gradients

A continuous gradient is one in which density increases linearly or non-linearly from top to bottom. Continuous gradients are generated by mixing two solutions of different densities in a gradient maker, or by centrifuging a pre-formed gradient at high speed to create a self-generated gradient (as with Percoll or iodixanol). Continuous gradients provide high resolution and are used when cells of very similar densities must be separated, such as isolating distinct lymphocyte subsets or separating basophils from other granulocytes.

A discontinuous (step) gradient consists of layers of solutions of decreasing density stacked in a tube, with the densest layer at the bottom. Blood is layered on top of the uppermost (least dense) layer. Cells sediment through the layers until they reach a layer denser than themselves, at which point they band at the interface. Discontinuous gradients are simpler to prepare, more reproducible, and sufficient for most blood cell separations. Ficoll-Paque separation is a discontinuous gradient with a single step at 1.077 g/mL. Percoll can be used as either a continuous or discontinuous gradient depending on the application.

The choice between continuous and discontinuous gradients depends on the required resolution. For PBMC isolation, a single-step discontinuous gradient is adequate because the density gap between mononuclear cells (≤1.077 g/mL) and granulocytes/erythrocytes (≥1.080 g/mL) is sufficiently large. For separating lymphocyte subpopulations (e.g., B cells from T cells), which differ in density by only 0.001–0.005 g/mL, a continuous gradient is required.

## Choosing the Right Gradient Medium

### Ficoll-Paque for Mononuclear Cell Isolation

Ficoll-Paque is a solution of Ficoll 400 (a high-molecular-weight sucrose polymer, MW ~400,000) and sodium diatrizoate, adjusted to a density of 1.077 g/mL and an osmolality of 280–320 mOsm/kg H₂O. The Ficoll provides the density, while the diatrizoate contributes to osmolality and density. Ficoll-Paque is the standard medium for PBMC isolation because it is inexpensive, reproducible, and well-characterized.

The mechanism of separation is as follows: whole blood (diluted 1:1 with phosphate-buffered saline or Hanks' balanced salt solution) is layered onto Ficoll-Paque. During centrifugation, erythrocytes aggregate and sediment rapidly through the Ficoll layer because their high density (1.090–1.110 g/mL) exceeds that of the medium. Granulocytes, with densities of 1.080–1.095 g/mL, also sediment through the Ficoll layer. Mononuclear cells, with densities of 1.065–1.077 g/mL, cannot penetrate the Ficoll layer and accumulate at the plasma–Ficoll interface. Platelets, being the least dense (1.04–1.06 g/mL), remain in the plasma layer above the interface.

A critical property of Ficoll-Paque is its low viscosity at 20 °C, which allows rapid sedimentation of erythrocytes and granulocytes. However, Ficoll is not isotonic at the concentrations used; the osmolality is maintained by the addition of sodium diatrizoate. This means that cells are exposed to a hypertonic environment during centrifugation, which can cause slight cell shrinkage. For most applications this is acceptable, but for assays sensitive to cell volume or osmotic stress, iodixanol may be preferable.

### Percoll for High-Purity Cell Subpopulations

Percoll is a suspension of colloidal silica particles (15–30 nm diameter) coated with polyvinylpyrrolidone (PVP) to render them inert and non-toxic. Percoll is supplied as a sterile stock solution with a density of 1.130 g/mL. It is diluted with isotonic saline or culture medium to achieve the desired density. Because Percoll particles are small and uniform, they do not penetrate cells and do not alter the osmolality of the medium significantly. Percoll gradients can be prepared as continuous gradients by centrifugation at high speed (20,000–30,000 × g for 15–30 minutes) to generate a self-forming gradient, or as discontinuous gradients by layering Percoll solutions of different densities.

The advantages of Percoll are its low osmolality (approximately 20 mOsm/kg H₂O for the stock solution), which allows preparation of isotonic gradients, and its ability to form continuous gradients for high-resolution separation. Percoll is the medium of choice for isolating granulocytes at high purity (>95%), for separating monocytes from lymphocytes (monocytes band at 1.068–1.077 g/mL, lymphocytes at 1.065–1.077 g/mL, with partial overlap), and for isolating natural killer cells or dendritic cells from PBMC preparations. The main disadvantage is that Percoll is more expensive than Ficoll-Paque and requires more preparation time, particularly for continuous gradients.

### Iodixanol for Gentle Separation

Iodixanol (sold commercially as OptiPrep) is a non-ionic iodinated density gradient medium. It is a tri-iodinated benzene derivative with multiple hydroxyl groups, making it highly water-soluble and non-toxic. Iodixanol solutions can be prepared at any density up to 1.32 g/mL and are iso-osmotic at densities up to approximately 1.15 g/mL. This is a significant advantage over Ficoll, which is hypertonic at the densities used for cell separation.

Iodixanol is the gentlest of the commonly used gradient media. It does not bind to cells, does not penetrate cell membranes, and does not activate platelets or leukocytes. It is therefore the medium of choice for isolating cells for functional assays where activation status must be preserved, for isolating platelets, and for separating cells from blood samples that have been stored or are of suboptimal quality. Iodixanol can be used to prepare both continuous and discontinuous gradients. For PBMC isolation, a discontinuous gradient with a layer of 1.077 g/mL iodixanol is used, with the caveat that the separation is slightly slower than with Ficoll because iodixanol has a higher viscosity at equivalent density.

A practical consideration with iodixanol is its cost, which is substantially higher than Ficoll-Paque. For routine PBMC isolation, Ficoll-Paque remains the most economical choice. Iodixanol is reserved for applications where cell activation status, viability, or yield of fragile cells is critical.

## Step-by-Step Protocol for [Density Gradient Centrifugation](/knowledge/molecular-biology/density-gradient-centrifugation)

The following protocol is for isolating PBMCs from human peripheral blood using Ficoll-Paque. It is the most common gradient centrifugation procedure and serves as a template for other cell types.

### Blood Collection and Anticoagulants

Blood should be collected into tubes containing an anticoagulant. The choice of anticoagulant affects cell viability and downstream applications:

- **Heparin** (lithium or sodium heparin, 15–30 IU/mL blood): Preserves cell viability and is suitable for most functional assays. Heparin does not chelate calcium, so it is compatible with assays requiring calcium.
- **EDTA** (K₂EDTA or K₃EDTA, 1.5–2.0 mg/mL blood): Chelates calcium and prevents complement activation. EDTA is preferred for flow cytometry because it prevents platelet activation and aggregation. However, EDTA can cause cell shrinkage and is not suitable for assays requiring calcium.
- **Sodium citrate** (3.2% or 3.8%, 1 part to 9 parts blood): The mildest anticoagulant in terms of cell morphology preservation. Citrate is preferred for platelet studies and coagulation assays.

For PBMC isolation, heparin or EDTA is recommended. Heparin gives slightly higher yields, while EDTA gives cleaner separation with less platelet contamination. Blood should be processed within 2–4 hours of collection for optimal viability. If blood must be stored, keep it at room temperature (18–25 °C) and do not refrigerate, as cold storage activates platelets and reduces PBMC yield.

### Layering Blood onto Gradient Medium

1. **Equilibrate reagents to room temperature.** Ficoll-Paque should be at 18–22 °C. Cold Ficoll-Paque increases viscosity and slows sedimentation, leading to poor separation.
2. **Dilute blood 1:1 with sterile phosphate-buffered saline (PBS) without Ca²⁺/Mg²⁺ or with Hanks' balanced salt solution (HBSS).** Dilution reduces blood viscosity and improves layering. For 10 mL of blood, add 10 mL of diluent and mix gently by inversion.
3. **Add 15 mL of Ficoll-Paque to a 50 mL conical centrifuge tube.** The volume of Ficoll-Paque should be approximately equal to the volume of diluted blood. For optimal separation, the ratio of diluted blood to Ficoll-Paque should be between 2:1 and 3:1.
4. **Carefully layer the diluted blood onto the Ficoll-Paque.** Tilt the tube to approximately 45° and slowly dispense the blood down the side of the tube using a serological pipette or a Pasteur pipette. The blood should form a distinct layer on top of the Ficoll-Paque. Do not allow the blood to mix with the Ficoll-Paque. The interface between the two layers should be sharp and visible. If the layers mix, the separation will be compromised.
5. **Do not disturb the tube after layering.** Any agitation will disrupt the interface and cause premature mixing.

### Centrifugation Conditions (Speed, Time, Temperature)

Centrifuge at **400–500 × g for 30–40 minutes at 18–20 °C** with the brake **off** (or set to the lowest setting). The acceleration can be set to maximum, but the deceleration must be gradual to avoid disturbing the gradient.

The g-force is calculated as the relative centrifugal force (RCF) at the midpoint of the tube. Most swinging-bucket rotors have a known radius; calculate the RPM using the formula:

RPM = √(RCF / (1.118 × 10⁻⁵ × r))

where r is the radius in centimeters. For a typical swinging-bucket rotor with a radius of 15 cm, 400 × g corresponds to approximately 1,500 RPM.

After centrifugation, the tube should show the following layers from top to bottom:

- **Plasma layer** (yellow, translucent) containing platelets
- **PBMC layer** (white, cloudy band) at the plasma–Ficoll interface
- **Ficoll-Paque layer** (clear)
- **Erythrocyte/granulocyte pellet** (red) at the bottom of the tube

### Harvesting the Desired Cell Layer

1. **Aspirate the plasma layer** using a sterile Pasteur pipette or a pipette attached to a vacuum trap. Leave approximately 0.5–1.0 cm of plasma above the PBMC layer to avoid disturbing it.
2. **Carefully collect the PBMC layer** using a fresh sterile Pasteur pipette. Tilt the tube slightly and aspirate the white band at the interface. Collect the entire band with minimal Ficoll-Paque. The volume of the PBMC layer is typically 2–4 mL per 10 mL of blood.
3. **Transfer the PBMC suspension to a fresh 50 mL conical tube.** Add 3 volumes of PBS or HBSS to dilute the Ficoll-Paque and wash the cells.
4. **Centrifuge at 300 × g for 10 minutes at room temperature** with the brake on. This is a washing step to remove residual Ficoll-Paque and platelets.
5. **Aspirate the supernatant** and resuspend the cell pellet in 5–10 mL of PBS or culture medium.
6. **Repeat the wash** (steps 4–5) one more time. Two washes are recommended to remove residual Ficoll-Paque, which can interfere with downstream assays.
7. **Resuspend the final cell pellet** in an appropriate volume of culture medium (e.g., RPMI-1640 with 10% fetal bovine serum) or buffer for downstream applications.

The entire procedure is summarized in the [Centrifugation Lab Experiment](/knowledge/molecular-biology/centrifugation-lab-experiment) resource, which provides additional context on rotor selection and tube preparation.

## Optimization of Centrifugation Parameters

### Effect of Centrifugation Speed and Time

The centrifugation speed and time are the most critical parameters affecting yield and purity. At speeds below 400 × g, erythrocytes and granulocytes may not fully sediment through the Ficoll-Paque layer, leading to contamination of the PBMC layer. At speeds above 500 × g, mononuclear cells may be forced through the Ficoll-Paque layer, reducing yield. The optimal speed depends on the rotor geometry and the height of the liquid column.

For a swinging-bucket rotor, the sedimentation path length is the distance from the sample–medium interface to the bottom of the tube. Longer path lengths require longer centrifugation times. As a general guideline:

- **400 × g for 30 minutes**: Standard for 50 mL tubes with 15 mL Ficoll-Paque and 30 mL diluted blood.
- **400 × g for 40 minutes**: Recommended for blood from donors with high hematocrit or high erythrocyte counts.
- **500 × g for 20 minutes**: May be used for smaller volumes (e.g., 15 mL tubes) where the path length is shorter.

If the yield is low, increase the centrifugation time rather than the speed. Increasing speed risks pushing cells through the gradient; increasing time allows complete sedimentation without exceeding the density threshold.

### Temperature Considerations

Centrifugation should be performed at **18–20 °C**. At lower temperatures (4 °C), the density and viscosity of Ficoll-Paque increase, slowing sedimentation and reducing yield. At higher temperatures (37 °C), cell metabolism is accelerated, which can affect cell viability and activation status. Room temperature is the standard for PBMC isolation.

For Percoll gradients, temperature is also critical because the density of Percoll solutions changes with temperature. Percoll stock solutions should be equilibrated to the centrifugation temperature before preparing gradients. The density of Percoll decreases by approximately 0.001 g/mL per °C increase, so a gradient prepared at 4 °C will have a different density profile at 20 °C.

### Using a Brake vs. No Brake

The brake should be **off** (or at the lowest setting) during the initial separation centrifugation. When the brake is applied, the deceleration creates a swirling motion in the tube that disrupts the gradient and causes mixing of the layers. This is the most common cause of poor separation and low yield.

For the washing steps (300 × g for 10 minutes), the brake can be on because the cells are already pelleted and the supernatant is being removed. However, if the cell pellet is loose or if the cells are fragile (e.g., after isolation from stored blood), use the brake at the lowest setting or turn it off entirely.

## Analysis and Quality Control of Isolated Cells

### Viability Assessment

Cell viability is assessed by trypan blue exclusion. Trypan blue is a diazo dye that is excluded from viable cells with intact membranes but penetrates dead cells, staining them blue. The assay is performed as follows:

1. Mix 10 µL of cell suspension with 10 µL of 0.4% trypan blue solution in PBS.
2. Incubate for 1–3 minutes at room temperature. Do not exceed 5 minutes, as trypan blue is toxic to cells over time.
3. Load 10 µL of the mixture onto a hemocytometer or an automated cell counter.
4. Count the number of viable (unstained) and dead (blue) cells. Calculate viability as:

Viability (%) = (Viable cells / Total cells) × 100

For PBMCs isolated by Ficoll-Paque, viability should be >95%. If viability is below 90%, the cells may have been damaged during isolation, and the protocol should be reviewed for issues such as excessive centrifugation speed, prolonged exposure to Ficoll-Paque, or delayed processing of blood.

### Purity Assessment by Flow Cytometry

Purity is assessed by flow cytometry using cell surface markers. For PBMCs, the expected composition is approximately 70–85% lymphocytes (CD45⁺, CD3⁺ for T cells, CD19⁺ for B cells, CD56⁺ for NK cells), 10–20% monocytes (CD14⁺), and <5% granulocytes (CD66b⁺ or CD15⁺). Contaminating erythrocytes are detected by glycophorin A (CD235a) staining.

A typical staining panel for PBMC purity assessment includes:

- **CD45** (pan-leukocyte marker) conjugated to a bright fluorophore (e.g., FITC or PerCP)
- **CD14** (monocyte marker) conjugated to PE
- **CD3** (T cell marker) conjugated to APC
- **CD66b** (granulocyte marker) conjugated to PE-Cy7

Stain 1 × 10⁵–1 × 10⁶ cells in 100 µL of FACS buffer (PBS with 2% fetal bovine serum and 0.1% sodium azide) with saturating concentrations of antibodies for 30 minutes at 4 °C in the dark. Wash twice with FACS buffer, resuspend in 200–300 µL, and acquire on a flow cytometer. Gate on CD45⁺ cells and determine the percentage of CD14⁺, CD3⁺, and CD66b⁺ cells within this gate.

### Yield Calculation

Yield is calculated as the total number of viable cells recovered per unit volume of blood processed. For PBMCs, the expected yield from healthy adult blood is 1–2 × 10⁶ PBMCs per mL of whole blood. This corresponds to approximately 10–20 × 10⁶ PBMCs from 10 mL of blood.

Yield is calculated as:

Yield (cells/mL blood) = (Total viable cell count) / (Volume of blood processed in mL)

If the yield is below 0.5 × 10⁶ cells/mL, the protocol should be reviewed. Common causes of low yield include:

- Blood stored for more than 4 hours before processing
- Centrifugation speed too low or time too short
- Loss of cells during harvesting (leaving part of the PBMC layer behind)
- Excessive washing steps with high-speed centrifugation

## Common Pitfalls and Troubleshooting

### Red Blood Cell Contamination

Red blood cell (RBC) contamination in the PBMC layer is the most common problem. It appears as a reddish tint in the white cell band. Causes and solutions:

- **Insufficient centrifugation speed or time**: Increase speed to 500 × g or extend time to 40 minutes.
- **Blood layered too thickly**: Reduce the volume of blood layered onto the Ficoll-Paque. The ratio of diluted blood to Ficoll-Paque should not exceed 3:1.
- **Ficoll-Paque density too low**: Verify the density of the Ficoll-Paque (should be 1.077 g/mL at 20 °C). Some commercial preparations may vary; check the lot certificate.
- **Blood from donors with abnormal erythrocyte density**: In conditions such as sickle cell disease or thalassemia, erythrocytes may have altered density and may not sediment properly. In such cases, use a higher-density medium (e.g., 1.083 g/mL) or a different separation strategy.

If RBC contamination persists, a brief hypotonic lysis can be performed: resuspend the cell pellet in 5 mL of ice-cold 0.2% NaCl for 30 seconds, then add 5 mL of 1.6% NaCl to restore isotonicity. Centrifuge at 300 × g for 10 minutes and resuspend in fresh medium. This step should be used sparingly, as it can reduce cell viability.

### Low Cell Yield

Low yield is the second most common problem. Causes and solutions:

- **Delayed processing**: Process blood within 2–4 hours of collection. If delay is unavoidable, store blood at room temperature and use a gentle anticoagulant (heparin).
- **Loss during harvesting**: Ensure that the entire PBMC layer is collected. Use a pipette to gently sweep the interface after the initial aspiration.
- **Excessive washing**: Limit to two washes. Each wash results in cell loss of 5–10%.
- **Centrifugation at too high speed**: Speeds above 500 × g can force mononuclear cells through the Ficoll-Paque layer. Verify the g-force by calculating the RPM for your specific rotor.

### Cell Aggregation or Clumping

Cell clumping after isolation is often caused by:

- **DNA released from dead cells**: Add DNase I (20 µg/mL) to the wash buffer to digest DNA and prevent clumping.
- **Platelet contamination**: Platelets can aggregate and bind to mononuclear cells. To reduce platelet contamination, perform an additional low-speed centrifugation (200 × g for 10 minutes) to pellet mononuclear cells while leaving platelets in suspension.
- **Cold temperature**: Cold activates platelets and can cause clumping. Keep cells at room temperature during processing.

### Gradient Disruption

Gradient disruption during centrifugation is usually caused by:

- **Brake applied during deceleration**: Always turn the brake off for the separation step.
- **Vibration or movement of the centrifuge**: Ensure the centrifuge is on a stable surface and the rotor is balanced.
- **Air bubbles in the gradient**: When layering blood onto Ficoll-Paque, avoid introducing air bubbles. Use a pipette with a slow, steady flow.

## Safety and Best Practices

### Biosafety Levels and PPE

Human blood is a potential biohazard and must be handled under Biosafety Level 2 (BSL-2) conditions. This requires:

- **Personal protective equipment (PPE)**: Lab coat, nitrile gloves, and safety glasses. Gloves should be changed if contaminated.
- **Work in a biosafety cabinet**: All steps involving blood handling, including layering, harvesting, and washing, should be performed in a certified biological safety cabinet (Class II).
- **Minimize aerosol generation**: Avoid vigorous pipetting or vortexing of blood samples. Use sealed tubes for centrifugation and open them only in the biosafety cabinet.

### Waste Disposal

All blood-contaminated materials—pipettes, tubes, gloves, and any disposable items—must be disposed of in biohazard waste containers. Liquid waste (residual blood, Ficoll-Paque, wash buffers) should be collected in a container with a disinfectant (e.g., 10% bleach) and autoclaved before disposal. Sharps (needles, scalpels) must be disposed of in puncture-resistant sharps containers. Institutional protocols for biohazard waste disposal must be followed at all times.

## Summary and Practical Considerations

### Quick Reference Guide

| Parameter | Recommended Setting |
|-----------|---------------------|
| Anticoagulant | Heparin (15–30 IU/mL) or EDTA (1.5–2.0 mg/mL) |
| Gradient medium | Ficoll-Paque (density 1.077 g/mL) for PBMCs |
| Blood dilution | 1:1 with PBS or HBSS |
| Blood-to-medium ratio | 2:1 to 3:1 |
| Centrifugation | 400–500 × g, 30–40 min, 18–20 °C, brake off |
| Washing | 2 washes at 300 × g for 10 min |
| Expected yield | 1–2 × 10⁶ PBMCs per mL blood |
| Expected viability | >95% |

### Final Tips for Reproducibility

- **Standardize blood collection**: Use the same anticoagulant and collection tube for all experiments. Note the time of collection and process samples within the same time window.
- **Equilibrate all reagents to room temperature** before starting. Cold reagents are the most common cause of inconsistent results.
- **Document centrifugation parameters**: Record the rotor model, radius, RPM, and time for every run. The g-force is only meaningful if the rotor radius is known.
- **Validate each new lot of gradient medium**: Different lots may have slight variations in density or osmolality. Test a new lot against the current lot before switching.
- **Perform quality control on every isolation**: Count cells, assess viability, and check purity by flow cytometry. Record these metrics in a laboratory notebook for trend analysis.

## Frequently Asked Questions

### What is the best anticoagulant for gradient centrifugation of blood?

Heparin is generally the best choice for PBMC isolation because it preserves cell viability and does not chelate calcium. EDTA is a good alternative for flow cytometry applications because it prevents platelet activation, but it can cause cell shrinkage and slightly lower yields. Sodium citrate is preferred for platelet studies but is not ideal for PBMC isolation because it requires a higher dilution factor. For most research applications, heparin is the recommended anticoagulant.

### How long should I centrifuge blood for gradient separation?

The standard protocol is 30–40 minutes at 400–500 × g. The exact time depends on the rotor geometry and the volume of blood. If the yield is low, increase the time to 40–45 minutes rather than increasing the speed. If the separation is incomplete (RBC contamination), increase the speed to 500 × g or extend the time to 45 minutes.

### Why do I get [red blood cell](/blog/guides/red-blood-cell) contamination in my mononuclear cell layer?

RBC contamination is usually caused by insufficient centrifugation speed or time, an excessive blood-to-medium ratio, or a gradient medium with a density below 1.077 g/mL. Verify the density of the Ficoll-Paque, reduce the volume of blood layered onto the medium, and ensure the brake is off during deceleration. If RBC contamination persists, consider using a higher-density medium or performing a hypotonic lysis step.

### Can I use a centrifuge brake during gradient centrifugation?

No. The brake must be off (or at the lowest setting) during the separation centrifugation. Applying the brake creates turbulence that disrupts the gradient and causes mixing of the layers. The brake can be used for the subsequent washing steps, but if the cell pellet is loose, use the lowest brake setting or turn it off.

### What is the difference between Ficoll and Percoll for blood cell separation?

Ficoll is a synthetic sucrose polymer that is used at a fixed density (1.077 g/mL) for PBMC isolation. It is inexpensive, simple to use, and suitable for most applications. Percoll is a colloidal silica suspension that can be prepared at any density and forms self-generated continuous gradients. Percoll provides higher resolution and is gentler on cells (lower osmolality), making it suitable for isolating granulocytes, monocytes, or rare cell populations. However, Percoll is more expensive and requires more preparation time.

### How do I improve the yield of peripheral blood mononuclear cells (PBMCs)?

Process blood within 2–4 hours of collection, use heparin as the anticoagulant, ensure all reagents are at room temperature, and use the correct centrifugation parameters (400–500 × g for 30–40 minutes with the brake off). Harvest the entire PBMC layer and limit washing to two steps. If yield remains low, check the density of the Ficoll-Paque and consider using a fresh lot.

### What is the principle behind density gradient centrifugation?

Density gradient centrifugation separates particles based on their buoyant density. When blood is layered onto a medium of defined density and centrifuged, cells sediment through the medium until they reach a position where the medium density equals their own. Cells denser than the medium (erythrocytes, granulocytes) pellet at the bottom, while cells less dense than the medium (mononuclear cells) band at the interface. The separation is governed by the sedimentation equation, which relates particle size, density difference, centrifugal force, and medium viscosity. For a more detailed explanation, see [Density Gradient Centrifugation](/knowledge/molecular-biology/density-gradient-centrifugation).

## Key Takeaways

- Gradient centrifugation of blood separates cells by buoyant density, with Ficoll-Paque (1.077 g/mL) being the standard medium for PBMC isolation.
- The physical basis is the sedimentation equation: cells sediment until their density equals that of the surrounding medium.
- Blood should be processed within 2–4 hours of collection, using heparin or EDTA as anticoagulant, and all reagents must be at room temperature.
- Centrifugation at 400–500 × g for 30–40 minutes at 18–20 °C with the brake off is the standard protocol for PBMC isolation.
- Expected yield is 1–2 × 10⁶ PBMCs per mL of blood with >95% viability; purity should be confirmed by flow cytometry.
- Common pitfalls include RBC contamination (increase speed or time), low yield (process blood promptly, harvest the entire band), and cell clumping (add DNase, reduce platelet contamination).
- Always handle blood under BSL-2 conditions with appropriate PPE and dispose of biohazard waste according to institutional protocols.

## Further Reading

- Jin J et al. *High-purity isolation platelets by gradient centrifugation plus filtration*. International journal of laboratory hematology. 2023. [PubMed 36470678](https://doi.org/10.1111/ijlh.13998)
- Dagur PK, McCoy JP Jr. *Collection, Storage, and Preparation of Human Blood Cells*. Current protocols in cytometry. 2015. [PubMed 26132177](https://doi.org/10.1002/0471142956.cy0501s73)
- André-Grégoire G, Roux Q, Gavard J. *Isolating plasma extracellular vesicles from mouse blood using size-exclusion chromatography, density gradient, and ultracentrifugation*. STAR protocols. 2023. [PubMed 38048217](https://doi.org/10.1016/j.xpro.2023.102740)
- Gray N et al. *Density Gradient Centrifugation-Independent Purification of Human Basophils*. Current protocols. 2024. [PubMed 38358026](https://doi.org/10.1002/cpz1.991)
- Tattikota SG, Perrimon N. *Preparation of Drosophila Larval Blood Cells for [Single-cell RNA Sequencing](/knowledge/bioinformatics/single-cell-rna-sequencing-from-bulk-to-resolution)*. Bio-protocol. 2021. [PubMed 34541045](https://doi.org/10.21769/BioProtoc.4127)
- Comità S et al. *Protocol for reticulocyte enrichment from low-volume human blood samples from alpha-thalassemic and healthy participants*. STAR protocols. 2024. [PubMed 39580806](https://doi.org/10.1016/j.xpro.2024.103455)

## Related Clinical & Scientific Guides

* [MAPK Pathway: Mechanism, Function, and Clinical Relevance](/knowledge/molecular-biology/mapk-pathway)
* [Mammalian Cell Culture Bioreactors: A Practical Guide](/knowledge/molecular-biology/mammalian-cell-culture-bioreactor)
* [Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks](/knowledge/molecular-biology/nucleotide-formation)